1. Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9;Abraham;Breast Cancer Res. Treat.,2015
2. E7389 versus capecitabine in patients with locally advanced or metastatic breast Cancer Previously treated with anthracyclines and taxanes;Anon;Clin. Trials.gov,2006
3. A study comparing eribulin mesylate and ixabepilone in causing or exacerbating neuropathy in patients with advanced breast Cancer;Anon;Clin. Trials.gov,2009
4. Halaven (erbulin mesylate) Injection: Highlights of Prescribing Information. US Food and Drug Administration;Anon,2010